FolioLanternBeta
EHCEncompass Health Corp · Insider ownership research

Encompass Health Corp insiders sold $47.8M in the past 12 months. How much of their stake is that?

Insiders sold $47.8M in the past 12 months.0% was sold under disclosed trading plans, 100% with no plan disclosed. The largest seller, Mark Tarr (President & CEO, Director), sold $38.5M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why

Updated Oct 13, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026
$47.8M
sold with no plan disclosed, past 12 months
0%
of sales were under disclosed trading plans, past 12 months
6 of 17
officers and directors sold shares, past 12 months
Is this normal? More than usual: about 6x the 5-year average. 6 insiders sold; the average is 3 a year. Year by year
Latest filing: Filed Sep 1 for a sale on Aug 31. John Darby sold 4.9K shares ($588K) with no plan disclosed. Filing
SEC ownership filings: 83 filed in the 12 months to Oct 13, 2026; 1,644 on record since Sep 16, 2003 · See the evidence

What stands out

Four officers sold $46.8M with no disclosed plan: Mark Tarr ($38.5M), Douglas Coltharp ($5.3M) and John Darby ($1.7M), plus 1 more. The filings don't state a reason.Mark Tarr: largest such sale, Aug 10, 2026 · Douglas Coltharp: largest such sale, May 15, 2026 · John Darby: largest such sale, Aug 10, 2026
Selling picked up in the last 90 days: officers and directors sold 211K shares, against an average of 63K per 90 days earlier in the period. Most of it was Mark Tarr (173K shares in the last 90 days) and Douglas Coltharp (19K shares in the last 90 days); 0% of these sales were under disclosed plans.Mark Tarr: largest recent sale, Aug 10, 2026 · Douglas Coltharp: largest recent sale, Aug 10, 2026

A share of stake is shown for 0 of the 6 officers and directors who sold. 17 are left out

i
Left out: Mark Tarr, Douglas Coltharp, Edmund Fay, John Darby, Andrew Price, Leslye Katz, Joan Herman, Nancy Schlichting, Patrick Tuer, Greg Carmichael, Terrance Williams, Christopher Reidy, Patricia Maryland, Elissa Charbonneau, Kevin O'Connor, Edward Christie III and Cain Hayes (share of stake is being verified).
Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Mark Tarr
President & CEO, Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$38.5MNo plan disclosed
Douglas Coltharp
EVP & Chief Financial Officer
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$5.3MNo plan disclosed
John Darby
EVP, Gen Counsel & Secretary
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$1.7MNo plan disclosed
Edmund Fay
Sr. Vice Pres. and Treasurer
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$1.3MNo plan disclosed
Andrew Price
Chief Accounting Officer
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$630KNo plan disclosed
All 6 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFeb 2026: $17.0M no plan disclosedFebMar 2026: $1.3M no plan disclosedMarAprMay 2026: $3.0M no plan disclosedMayJunJulAug 2026: $26.4M no plan disclosed$26.4MAugSepOct

Recent activity

Past 30 days, Sep 14, 2026 to Oct 13, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Aug 31, 20262 executives sold 10K shares ($1.2M) with no plan disclosed. 4.9K shares came in from vesting or option exercises the same day, so their combined holdings fell by 5.2K net.
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Andrew Price
Chief Accounting Officer
5,211$120.93n/an/aAug 31, 2026Sep 1, 2026
John Darby
EVP, Gen Counsel & Secretary
4,858$121.09n/an/aAug 31, 2026Sep 1, 2026

Common questions

Is the Encompass Health Corp CEO selling stock?

Yes. Mark Tarr sold 323K shares ($38.5M) in the past 12 months, none of it under a trading plan disclosed in the filings.

Why are Encompass Health Corp insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any Encompass Health Corp insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold6 officers and directors: amount, % of holdings, trading plan
Who soldAmount% of holdingsTrading plan
Mark Tarr
President & CEO, Director
$38.5M
323K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
Douglas Coltharp
EVP & Chief Financial Officer
$5.3M
47K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
John Darby
EVP, Gen Counsel & Secretary
$1.7M
14K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
Edmund Fay
Sr. Vice Pres. and Treasurer
$1.3M
12K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
Andrew Price
Chief Accounting Officer
$630K
5.2K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
Patrick Tuer
EVP, Chief Operating Officer
$373K
3.5K shares
Not confirmed
share of stake is being verified. Why
No plan disclosed
The full ownership picture0 of 17 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 13, 2025SoldHeld Oct 13, 2026Still held
Mark Tarr
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Mark Tarr are complete.
President & CEO, Director
n/a−323Kn/an/a
Vesting, gifts, unvested awards and holding lines for Mark Tarr

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mark Tarr are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−50Kwithheld by the company for taxes

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
41,524$74.20Mar 1, 2034$1.9M
33,086$98.45Mar 4, 2035$744K
35,461$108.06Mar 2, 2036$456K

Estimate: options held × ($120.93 − strike price), using the most recent insider trade price on Form 4 (Aug 31, 2026), not a market close.

Douglas Coltharp
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Douglas Coltharp are complete.
EVP & Chief Financial Officer
n/a−47Kn/an/a
Vesting, gifts, unvested awards and holding lines for Douglas Coltharp

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Douglas Coltharp are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−33Kwithheld by the company for taxes

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
14,735$74.20Mar 1, 2034$689K
12,407$98.45Mar 4, 2035$279K
12,275$108.06Mar 2, 2036$158K

Estimate: options held × ($120.93 − strike price), using the most recent insider trade price on Form 4 (Aug 31, 2026), not a market close.

Edmund Fay
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Edmund Fay are complete.
Sr. Vice Pres. and Treasurer
n/a−12Kn/an/a
Vesting, gifts, unvested awards and holding lines for Edmund Fay

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Edmund Fay are complete; balances and unit counts will be added when the check is finished.

−3Kgifted (net of own trusts)
−4.3Kwithheld by the company for taxes
John Darby
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for John Darby are complete.
EVP, Gen Counsel & Secretary
n/a−14Kn/an/a
Vesting, gifts, unvested awards and holding lines for John Darby

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Darby are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−16Kwithheld by the company for taxes

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
7,894$74.20Mar 1, 2034$369K
6,032$98.45Mar 4, 2035$136K
5,967$108.06Mar 2, 2036$77K

Estimate: options held × ($120.93 − strike price), using the most recent insider trade price on Form 4 (Aug 31, 2026), not a market close.

Andrew Price
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Andrew Price are complete.
Chief Accounting Officer
n/a−5.2Kn/an/a
Vesting, gifts, unvested awards and holding lines for Andrew Price

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Andrew Price are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−4.6Kwithheld by the company for taxes
Leslye Katz
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Leslye Katz are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Leslye Katz

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Leslye Katz are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Joan Herman
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Joan Herman are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Joan Herman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Joan Herman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Nancy Schlichting
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Nancy Schlichting are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Nancy Schlichting

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Nancy Schlichting are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Patrick Tuer
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patrick Tuer are complete.
EVP, Chief Operating Officer
n/a−3.5Kn/an/a
Vesting, gifts, unvested awards and holding lines for Patrick Tuer

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patrick Tuer are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−4.6Kwithheld by the company for taxes

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
10,502$108.06Mar 2, 2036$135K

Estimate: options held × ($120.93 − strike price), using the most recent insider trade price on Form 4 (Aug 31, 2026), not a market close.

Greg Carmichael
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Greg Carmichael are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Greg Carmichael

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Greg Carmichael are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Terrance Williams
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Terrance Williams are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Terrance Williams

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Terrance Williams are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Christopher Reidy
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Christopher Reidy are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Christopher Reidy

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Christopher Reidy are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Patricia Maryland
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patricia Maryland are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Patricia Maryland

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patricia Maryland are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Elissa Charbonneau
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Elissa Charbonneau are complete.
Chief Medical Officer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Elissa Charbonneau

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Elissa Charbonneau are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−5.1Kwithheld by the company for taxes
Kevin O'Connor
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Kevin O'Connor are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Kevin O'Connor

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kevin O'Connor are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Edward Christie III
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Edward Christie III are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Edward Christie III

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Edward Christie III are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Cain Hayes
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Cain Hayes are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Cain Hayes

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Cain Hayes are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Encompass Health Corp are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$47.8M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $47.8M across 404,109 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $47.8M

Sales with no 10b5-1 plan and no tax reference in the filing. $38.5M of it is Mark Tarr. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Mark Tarr, Aug 10, 2026

Taxes

117,202 shares ($12.5M) were withheld by the company for taxes, which isn't a market sale.

Charitable gifts · 3K shares

Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.

SellerShares soldProceedsUnder a disclosed planShare of totalSales dates
Mark Tarr
President & CEO, Director
323K$38.5M0%81%Feb 11, 2026 to Aug 10, 2026
Douglas Coltharp
EVP & Chief Financial Officer
47K$5.3M0%11%May 15, 2026 to Aug 10, 2026
John Darby
EVP, Gen Counsel & Secretary
14K$1.7M0%4%Aug 10, 2026 to Aug 31, 2026
Edmund Fay
Sr. Vice Pres. and Treasurer
12K$1.3M0%3%Mar 9, 2026 to Mar 9, 2026
Andrew Price
Chief Accounting Officer
5.2K$630K0%1%Aug 31, 2026 to Aug 31, 2026
Patrick Tuer
EVP, Chief Operating Officer
3.5K$373K0%0.8%Feb 10, 2026 to May 11, 2026

Sales by month

MonthSale proceedsDisclosed planTo cover taxesNo plan disclosed
Oct 2025$0$0$0$0
Nov 2025$0$0$0$0
Dec 2025$0$0$0$0
Jan 2026$0$0$0$0
Feb 2026$17.0M$0$0$17.0M
Mar 2026$1.3M$0$0$1.3M
Apr 2026$0$0$0$0
May 2026$3.0M$0$0$3.0M
Jun 2026$0$0$0$0
Jul 2026$0$0$0$0
Aug 2026$26.4M$0$0$26.4M
Sep 2026$0$0$0$0
Oct 2026$0$0$0$0
Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 6x the 5-year average. 6 insiders sold; the average is 3 a year.

12 months endingShares soldInsiders who soldProceeds
Oct 13, 2026
Latest 12 months
404K6$47.8M
Oct 13, 2025
1 year earlier
182K6$21.7M
Oct 13, 2024
2 years earlier
93K4$7.6M
Oct 14, 2023
3 years earlier
52K3$3.5M
Oct 14, 2022
4 years earlier
20K1$1.1M
Oct 14, 2021
5 years earlier
15K2$1.2M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty17 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Encompass Health Corp are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,644 filings on record, 83 filed in the 12-month period, and how we read them

All 1,644 Forms 3, 4 and 5 on record for Encompass Health Corp (SEC CIK 785161), filed from Sep 16, 2003 to Sep 1, 2026; 83 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages. 2 filings were left out because Encompass Health Corp filed them as an owner of another company's stock.

Probable 1-for-5 stock split on or before Oct 25, 2006 (split date stated in a footnote). Splits aren't reported as transactions; 18 holding lines changed by exactly this ratio, so earlier share counts are restated.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (34)No filing in 18 months; last reported balances, not in any total
NameLast filedLast reported balance
Donald CorrellApr 16, 2024165,922 shares, last reported balance as of Apr 15, 2024
John ChidseyApr 16, 2024268,411 shares, last reported balance as of Apr 16, 2024
Barbara JacobsmeyerJan 13, 202391,406 shares, last reported balance as of Mar 9, 2022
John Maupin Jr.Apr 20, 2022149,160 shares, last reported balance as of Apr 19, 2022
Leo Higdon Jr.Apr 20, 2022145,545 shares, last reported balance as of Apr 18, 2022
Charles ElsonApr 20, 2022152,725 shares, last reported balance as of Apr 18, 2022
Yvonne CurlApr 20, 2022143,179 shares, last reported balance as of Apr 18, 2022
Edward Shaw Jr.Apr 20, 2022184,594 shares, last reported balance as of Apr 19, 2022
April AnthonyJan 12, 2022724,111 shares, last reported balance as of Jun 18, 2021
Cheryl LevyFeb 26, 2019141,236 shares, last reported balance as of Feb 25, 2019
Jay GrinneyJan 3, 20171,231,767 shares, last reported balance as of Dec 31, 2016
John WhittingtonFeb 22, 2016251,854 shares, last reported balance as of Feb 18, 2016
Dexanne ClohanAug 4, 2015109,120 shares, last reported balance as of Jul 31, 2015
Jon HansonApr 17, 2014106,970 shares, last reported balance as of Apr 16, 2014
Edward BlechschmidtApr 12, 201252,844 shares, last reported balance as of Apr 11, 2012
John WorkmanNov 19, 200972,716 shares, last reported balance as of Nov 17, 2009
John MarkusAug 7, 20075,942 shares, last reported balance as of Aug 4, 2007
Diane MunsonAug 2, 20075,772 shares, last reported balance as of Jul 31, 2007
Michael SnowJul 2, 200717,548 shares, last reported balance as of Jun 30, 2007
Joseph ClarkJul 2, 20071,569 shares, last reported balance as of Jun 30, 2007
Gregory BrophyMar 6, 200712,000 shares, last reported balance as of Mar 2, 2007
Gregory DoodyAug 1, 2006No balance on record
Steven BerrardMay 19, 20064,995 shares, last reported balance as of May 18, 2006
Karen DavisFeb 24, 20066,180 shares, last reported balance as of Mar 23, 2005
James FoxworthyFeb 24, 200628,884 shares, last reported balance as of Feb 23, 2006
Robert MayOct 24, 20054,706 shares, last reported balance as of Oct 20, 2005
Joel GordonMay 11, 2005295,084 shares, last reported balance as of May 10, 2005
Lee HillmanFeb 22, 2005405 shares, last reported balance as of Feb 18, 2005
Patrick FosterMay 20, 200416,630 shares, last reported balance as of May 20, 2004
Larry TaylorMar 9, 200414,740 shares, last reported balance as of Mar 5, 2004
George StrongJan 30, 200446,892 shares, last reported balance as of Jan 29, 2004
John ChamberlinJan 22, 200428,086 shares, last reported balance as of Jan 20, 2004
Sage GivensJan 22, 20048,706 shares, last reported balance as of Jan 20, 2004
Larry Striplin Jr.Jan 22, 200414,686 shares, last reported balance as of Jan 20, 2004

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.